Signal pathways of melanoma and targeted therapy

W Guo, H Wang, C Li - Signal transduction and targeted therapy, 2021 - nature.com
Melanoma is the most lethal skin cancer that originates from the malignant transformation of
melanocytes. Although melanoma has long been regarded as a cancerous malignancy with …

Targeting TGF-β signal transduction for fibrosis and cancer therapy

D Peng, M Fu, M Wang, Y Wei, X Wei - Molecular cancer, 2022 - Springer
Transforming growth factor β (TGF-β) has long been identified with its intensive involvement
in early embryonic development and organogenesis, immune supervision, tissue repair, and …

Lysosome biogenesis: Regulation and functions

C Yang, X Wang - Journal of Cell Biology, 2021 - rupress.org
Lysosomes are degradation centers and signaling hubs in cells and play important roles in
cellular homeostasis, development, and aging. Changes in lysosome function are essential …

The journey from melanocytes to melanoma

PP Centeno, V Pavet, R Marais - Nature Reviews Cancer, 2023 - nature.com
Over the past decade, melanoma has led the field in new cancer treatments, with impressive
gains in on-treatment survival but more modest improvements in overall survival. Melanoma …

Targeting the RAS/RAF/MAPK pathway for cancer therapy: from mechanism to clinical studies

ME Bahar, HJ Kim, DR Kim - Signal transduction and targeted therapy, 2023 - nature.com
Metastatic dissemination of solid tumors, a leading cause of cancer-related mortality,
underscores the urgent need for enhanced insights into the molecular and cellular …

Persistent cancer cells: the deadly survivors

S Shen, S Vagner, C Robert - Cell, 2020 - cell.com
Persistent cancer cells are the discrete and usually undetected cells that survive cancer drug
treatment and constitute a major cause of treatment failure. These cells are characterized by …

TGF-β signaling and resistance to cancer therapy

M Zhang, YY Zhang, Y Chen, J Wang… - Frontiers in Cell and …, 2021 - frontiersin.org
The transforming growth factor β (TGF-β) pathway, which is well studied for its ability to
inhibit cell proliferation in early stages of tumorigenesis while promoting epithelial …

Autophagy as a therapeutic target in pancreatic cancer

M Piffoux, E Eriau, PA Cassier - British Journal of Cancer, 2021 - nature.com
Pancreatic ductal adenocarcinoma (PDAC) is characterised by early metastasis and
resistance to anti-cancer therapy, leading to an overall poor prognosis. Despite continued …

Transcriptional regulation of autophagy: mechanisms and diseases

C Di Malta, L Cinque, C Settembre - Frontiers in cell and …, 2019 - frontiersin.org
Macro (Autophagy) is a catabolic process that relies on the cooperative function of two
organelles: the lysosome and the autophagosome. The recent discovery of a transcriptional …

Stem cell plasticity and dormancy in the development of cancer therapy resistance

ML De Angelis, F Francescangeli, F La Torre… - Frontiers in …, 2019 - frontiersin.org
Cancer treatment with either standard chemotherapy or targeted agents often results in the
emergence of drug-refractory cell populations, ultimately leading to therapy failure. The …